September 21, 2022
Following the success of the November 2021 focus groups for IgG4-RD patients, the Alliance for Patience Access hosted another focus group to capture additional insights.
September 20, 2022
The U.S. Food and Drug Administration’s standard approval process for new drugs delivers patients the safest, most advanced medications in the world.
August 18, 2022
Hepatitis C is a paradox of American health care. The medical community has never been better equipped to diagnose, cure and prevent this potentially fatal liver disease.
May 24, 2022
A 2022 survey from the Alliance for Mental Health Care Access examined the effects non-medical switching has on mental health patients.
April 27, 2022
Biologic drugs, including biosimilars, are increasing the number of effective treatments for rheumatic diseases. Biologics are derived from living organisms,…
April 14, 2022
In today’s technologically advanced world, devices and apps are changing the way people manage their health.
March 29, 2022
Perhaps no specialty in American medicine better illustrates the value of patient-centered care – and the costs of obstacles to…
March 24, 2022
Biomarkers are predictive markers in genetic material that can indicate which medications might work for a given patient. For cancer patients, biomarker testing is an important first step toward tailored treatment.
March 9, 2022
Non-medical switching is a complicated obstacle for mental health care providers and their patients to overcome.
February 11, 2022
Shared decision-making and a trusted physician-patient relationship are cornerstones of patient-centered care. Sometimes, however, health insurers can disrupt care by…
